St Erik Eye Hospital

The trials here

What the 5 trials at this site are about, from their registry records.

Conditions

• Macular degeneration3 trials
• Melanoma1 trial
• Retinitis pigmentosa1 trial

Phase

• Phase 11 trial
• Phase 1/21 trial
• Phase 21 trial
• Phase 2/31 trial
• Phase 31 trial

Status

• Completed3 trials
• Active, not recruiting1 trial
• Not yet recruiting1 trial

Lead sponsor

• Janssen Research & Development, LLC2 trials
• Aura Biosciences1 trial
• Novartis Pharmaceuticals1 trial
• St Erik Eye Hospital1 trial

Running trials

• Not yet recruiting

  CellThRPE1

  2024-517546-33-00· Phase 1· St Erik Eye Hospital· Source

• Recruiting

  A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT06635148· Phase 2/3· Janssen Research & Development, LLC· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Macular degeneration1 recruiting

Closed trials

• Active, not recruiting

  A Phase 3 Randomized, Masked, Controlled Trial to Evaluate Efficacy and Safety of Belzupacap Sarotalocan (AU-011) Treatment Compared to Sham Control in Subjects With Primary Indeterminate Lesions or Small Choroidal Melanoma

  NCT06007690· Phase 3· Aura Biosciences· Source

• Completed

  A Study to Evaluate Intravitreal JNJ-81201887 (AAVCAGsCD59) Compared to Sham Procedure for the Treatment of Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

  NCT05811351· Phase 2· Janssen Research & Development, LLC· Source

• Completed

  A First-in-human, Proof of Concept Study of CPK850 in Patients With RLBP1 Retinitis Pigmentosa

  NCT03374657· Phase 1/2· Novartis Pharmaceuticals· Source